These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19175355)

  • 1. The protective effects of exercise and phosphoinositide 3-kinase (p110alpha) in the failing heart.
    Owen KL; Pretorius L; McMullen JR
    Clin Sci (Lond); 2009 Mar; 116(5):365-75. PubMed ID: 19175355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.
    Weeks KL; Gao X; Du XJ; Boey EJ; Matsumoto A; Bernardo BC; Kiriazis H; Cemerlang N; Tan JW; Tham YK; Franke TF; Qian H; Bogoyevitch MA; Woodcock EA; Febbraio MA; Gregorevic P; McMullen JR
    Circ Heart Fail; 2012 Jul; 5(4):523-34. PubMed ID: 22705768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy.
    McMullen JR; Amirahmadi F; Woodcock EA; Schinke-Braun M; Bouwman RD; Hewitt KA; Mollica JP; Zhang L; Zhang Y; Shioi T; Buerger A; Izumo S; Jay PY; Jennings GL
    Proc Natl Acad Sci U S A; 2007 Jan; 104(2):612-7. PubMed ID: 17202264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aerobic or aerobic and resistance training on cardiorespiratory and skeletal muscle function in heart failure: a randomized controlled pilot trial.
    Mandic S; Tymchak W; Kim D; Daub B; Quinney HA; Taylor D; Al-Kurtass S; Haykowsky MJ
    Clin Rehabil; 2009 Mar; 23(3):207-16. PubMed ID: 19218296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice.
    Inuzuka Y; Okuda J; Kawashima T; Kato T; Niizuma S; Tamaki Y; Iwanaga Y; Yoshida Y; Kosugi R; Watanabe-Maeda K; Machida Y; Tsuji S; Aburatani H; Izumi T; Kita T; Shioi T
    Circulation; 2009 Oct; 120(17):1695-703. PubMed ID: 19822807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waltz dancing in patients with chronic heart failure: new form of exercise training.
    Belardinelli R; Lacalaprice F; Ventrella C; Volpe L; Faccenda E
    Circ Heart Fail; 2008 Jul; 1(2):107-14. PubMed ID: 19808280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise in chronic heart failure: does it need to be "anti-remodeling"?
    Conraads V; Beckers P; Vrints CJ
    J Am Coll Cardiol; 2007 Dec; 50(24):2355-6; author reply 2356. PubMed ID: 18068048
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging concepts in exercise training in chronic heart failure.
    Villani GQ; Capucci A; Piepoli MF
    Ital Heart J; 2000 Dec; 1(12):795-800. PubMed ID: 11152410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise training in congestive heart failure. A review of the current status.
    Larsen AI; Dickstein K
    Minerva Cardioangiol; 2005 Aug; 53(4):275-86. PubMed ID: 16177672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting physiological hypertrophy in the failing heart.
    Pretorius L; Owen KL; Jennings GL; McMullen JR
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):438-41. PubMed ID: 18307737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Responder analysis" for assessing effectiveness of heart failure therapies based on measures of exercise tolerance.
    Burkhoff D; Parides M; Borggrefe M; Abraham WT; Kadish A
    J Card Fail; 2009 Mar; 15(2):108-15. PubMed ID: 19254669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific role of phosphoinositide 3-kinase p110alpha in the regulation of phagocytosis and pinocytosis in macrophages.
    Tamura N; Hazeki K; Okazaki N; Kametani Y; Murakami H; Takaba Y; Ishikawa Y; Nigorikawa K; Hazeki O
    Biochem J; 2009 Sep; 423(1):99-108. PubMed ID: 19604150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in hemoglobin-oxygen affinity results in the improvement of exercise capacity in mice with chronic heart failure.
    Watanabe T; Takeda T; Omiya S; Hikoso S; Yamaguchi O; Nakano Y; Higuchi Y; Nakai A; Abe Y; Aki-Jin Y; Taniike M; Mizote I; Matsumura Y; Shimizu T; Nishida K; Imai K; Hori M; Shirasawa T; Otsu K
    J Am Coll Cardiol; 2008 Aug; 52(9):779-86. PubMed ID: 18718428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted inhibition of phosphoinositide 3-kinase activity as a novel strategy to normalize beta-adrenergic receptor function in heart failure.
    Perrino C; Rockman HA; Chiariello M
    Vascul Pharmacol; 2006 Aug; 45(2):77-85. PubMed ID: 16807128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracrine effects of cell transplantation: modifying ventricular remodeling in the failing heart.
    Fedak PW
    Semin Thorac Cardiovasc Surg; 2008; 20(2):87-93. PubMed ID: 18707639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of physical training in patients with heart failure].
    Voors AA
    Ned Tijdschr Geneeskd; 2009; 153():A666. PubMed ID: 19785833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of exercise capacity improvement after exercise training program: a strong prognostic factor in patients with chronic heart failure.
    Tabet JY; Meurin P; Beauvais F; Weber H; Renaud N; Thabut G; Cohen-Solal A; Logeart D; Ben Driss A
    Circ Heart Fail; 2008 Nov; 1(4):220-6. PubMed ID: 19808295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure.
    Ohtani T; Mano T; Hikoso S; Sakata Y; Nishio M; Takeda Y; Otsu K; Miwa T; Masuyama T; Hori M; Yamamoto K
    J Hypertens; 2009 May; 27(5):1074-83. PubMed ID: 19349910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endurance exercise and resistance training in cardiovascular disease.
    Meka N; Katragadda S; Cherian B; Arora RR
    Ther Adv Cardiovasc Dis; 2008 Apr; 2(2):115-21. PubMed ID: 19124415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
    Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
    Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.